Pachychoroid pigment epitheliopathy

Retina

Volumn 33, Issue 8, 2013, Pages 1659-1672

  Warrow, David J ^a   Hoang, Quan V ^b,c,d   Freund, K Bailey ^b,c,d,e  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^c EAR AND THROAT HOSPITAL   (United States)

^d New York Presbyterian Hospital   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

central; chorioretinopathy; choroidal; forme; fruste; serous; thickening

Indexed keywords

BRCA1 PROTEIN; CORTICOSTEROID; METOPROLOL; VISUAL PIGMENT;

ADULT; AGED; AMBLYOPIA; ARTICLE; ASYMPTOMATIC DISEASE; AUTOFLUORESCENCE; BIOMICROSCOPY; CATARACT; CENTRAL SCOTOMA; CHORIORETINOPATHY; CHOROID; CHOROID VASCULARIZATION; CHOROIDITIS; CLINICAL ARTICLE; CROHN DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; HEART ATRIUM FIBRILLATION; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPE; OPHTHALMOSCOPY; OVARY CYST; PACHYCHOROID PIGMENT EPITHELIOPATHY; PATIENT REFERRAL; PIGMENT DISORDER; THYROIDECTOMY; THYROIDITIS; TRANSITIONAL BLINDNESS; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; CENTRAL SEROUS CHORIORETINOPATHY; CHOROID; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; POLYPS; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84883743682     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182953df4     Document Type: Article

References (59)

1. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967;63:1-139.
2. Von Graefe A. Ueber central recidivierende retinitis. Graefes Arch Clin Exp Ophthalmol 1866;12:211-215.
3. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 2011;31:1603-1608.
4. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29:1469-1473.
5. Kim YT, Kang SW, Bai KH. Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy. Eye (Lond) 2011;25:1635-1640.
6. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010;117:1792-1799.
7. Maumenee AE. Macular diseases clinical manifestations. Trans Am Acad Ophthalmol Otolaryngol 1965;69:605-613.
8. Van Velthoven MEJ, Verbraak FD, Garcia PM, et al. Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol 2005;89:1483-1488.
9. Prünte C. Indocyanine green angiographic findings in central serous chorioretinopathy. Int Ophthalmol 1995;19:77-82.
10. Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina 2012;32:1829-1837.
11. Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007;27:589-594.
12. Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
13. Kitaya N, Nagaoka T, Hikichi T, et al. Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 2003;87:709-712.
14. Iijima H, Iida T, Murayama K, et al. Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol 1999;127:477-478.
15. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010;150:325-329.
16. Moisseiev J, Neuman D, Treister G. Idiopathic central serous choroidopathy (ICSC). Retina 1989;9:153-154.
17. Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol 2008;86:126-145.
18. Gass JDM. Stereoscopic Atlas of Macular Disease. St Louis, MO: Mosby-Year Book; 1987:46-54.
19. Gupta P, Gupta V, Dogra MR, et al. Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol 2010;30:175-181.
20. Fossarello M, Peiretti E, Zucca I, Serra A. Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium. Eur J Ophthalmol 2004;14:568-571.
21. Göncü T, Ozdek S. Idiopathic multiple tiny serous retinal pigment epithelial detachments: report of 2 cases and review of the literature. Optometry 2011;82:556-562.
22. Gass JD, Bressler SB, Akduman L, et al. Bilateral idiopathic multifocal retinal pigment epithelium detachments in otherwise healthy middle-aged adults: a clinicopathologic study. Retina 2005;25:304-310.
23. Giovannini A, Scassellati-Sforzolini B, D'Altobrando E, et al. Choroidal findings in the course of idiopathic serous pigment epithelium detachment detected by indocyanine green video angiography. Retina 1997;17:286-293.
24. Gomez-Ulla F, Vazquez JM, Rodriguez-Cid MJ, et al. Central serous chorioretinopathy following pigment epithelium detachment: fluorescein and indocyanine green angiography follow-up. Acta Ophthalmol Scand 2000;78:232-234.
25. Bandello F, Incorvaia C, Parmeggiani F, Sebastiani A. Idiopathic multiple serous detachments of the retinal pigment epithelium followed by bilateral central serous chorioretinopathy: a case report. Ophthalmologica 2000;214:362-367.
26. Mendrinos E, Mavrakanas N, Dang-Burgener NP, Pournaras CJ. Bilateral multifocal retinal pigment epithelium detachments associated with systemic corticosteroids. Eur J Ophthalmol 2008;18:649-651.
27. Guyer DR, Yannuzzi LA, Slakter JS, et al. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112:1057-1062.
28. Iida T, Hagimura N, Otani T, et al. Choroidal vascular lesions in serous retinal detachment viewed with indocyanine green angiography. Nippon Ganka Gakkai Zasshi 1996;100:817-824.
29. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-815.
30. Goldenberg D, Moisseiev E, Goldstein M, et al. Enhanced depth imaging optical coherence tomography: choroidal thickness and correlations with age, refractive error, and axial length. Ophthalmic Surg Lasers Imaging 2012;43:296-301.
31. Cohen D, Gaudric A, Coscas G, et al. Epitheliopathie rétinienne diffuse et choriorétinopathie séreuse centrale. J Fr Ophtalmol 1983;6:339-349.
32. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 1992;2:103-114.
33. Bujarborua D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand 2001;79:417-421.
34. Dinc UA, Tatlipinar S, Yenerel M, et al. Fundus autofluorescence in acute and chronic central serous chorioretinopathy. Clin Exp Optom 2011;94:452-457.
35. Framme C, Walter A, Gabler B, et al. Fundus autofluorescence in acute and chronic recurrent central serous chorioretinopathy. Acta Ophthalmol Scand 2005;83:161-167.
36. von Rückmann A, Fitzke FW, Fan J, et al. Abnormalities of fundus autofluorescence in central serous retinopathy. Am J Ophthalmol 2002;133:780-786.
37. Spaide RF, Klancnik JM Jr. Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology 2005;112:825-833.
38. Imamura Y, Fujiwara T, Spaide RF. Fundus autofluorescence and visual acuity in central serous chorioretinopathy. Ophthalmology 2011;118:700-705.
39. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 1986;84:799-845.
40. Tittl MK, Spaide RF, Wong D, et al. Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol 1999;128:63-68.
41. Yoshioka H. The etiology of central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi 1991;95:1181-1195.
42. Sun J, Tan J, Wang Z, et al. Effect of catecholamine on central serous chorioretinopathy. J Huazhong Univ Sci Technolog Med Sci 2003;23:313-316.
43. Gass JD. Central serous chorioretinopathy and white subretinal exudation during pregnancy. Arch Ophthalmol 1991;109:677-681.
44. Abe S, Yamamoto T, Haneda S, et al. Three-Dimensional Features of Polypoidal Choroidal Vasculopathy Observed by Spectral-Domain OCT. Ophthalmic Surg Lasers Imaging. 2010 Mar 9: 1-6. doi: 10.3928/15428877-20100215-76. [Epub ahead of print]
45. Khan S, Engelbert M, Imamura Y, Freund KB. Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina 2012;32:1057-1068.
46. Tsujikawa A, Ojima Y, Yamashiro K, et al. Development of polypoidal lesions in age-related macular degeneration. Eye (Lond) 2011;25:481-488.
47. Tamura H, Tsujikawa A, Otani A, et al. Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. Br J Ophthalmol 2007;91:1152-1159.
48. Baillif-Gostoli S, Quaranta-El Maftouhi M, Mauget-Faÿsse M. Polypoidal choroidal vasculopathy in a patient with angioid streaks secondary to pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 2010;248:1845-1848.
49. Mauget-Faÿsse M, Cornut PL, Quaranta El-Maftouhi M, Leys A. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma. Am J Ophthalmol 2006;142:970-975.
50. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 2010;30:1333-1349.
51. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006;142:601-607.
52. Ahuja RM, Downes SM, Stanga PE, et al. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001;108:1009-1010.
53. Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000;107:767-777.
54. Ueta T, Obata R, Inoue Y, et al. Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009; 116:2400-2406.
55. Piccolino FC, Borgia L, Zinicola E, et al. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye (Lond) 1995;9:324-332
56. Jirarattanasopa P, Ooto S, Nakata I, et al. Choroidal thickness, vascular permeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2012;53: 3663-3672.
57. Maruko I, Iida T, Sugano Y, et al. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2011; 151:594-603.
58. Koizumi H, Yamagishi T, Yamazaki T, Kinoshita S. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol 2013;155:305-313.
59. Koizumi H, Yamagishi T, Yamazaki T, et al. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2011;249:1123-1128.